Formulation Development Solutions

31. Cell Culture Media For Viral Vector Production 11/3/2025

    Support high-yield viral vector production with media designed for transfection efficiency, scalability, and reduced aggregation in HEK293 cells, ideal for AAV and LV workflows.

32. Steroids: Development And Manufacturing 3/17/2026

    As a dedicated center of excellence in this product family, we offer a high degree of versatility and tailored solutions to meet the specific needs of each client.

33. Early Development: Accelerating Molecules Through To Proof-Of-Concept 3/3/2022

    Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.

34. Peptide & Oligonucleotide: CDMO Overview 3/11/2026

    Explore a focused overview of modern TIDES development, from advanced synthetic options to AI‑supported modeling and integrated purification strategies. Gain clarity on scalable manufacturing approaches that help streamline timelines and support reliable peptide and oligonucleotide production.

35. A Revolutionary Consumable Empowering High-Throughput Organ-Chip Studies 12/18/2025

    With 12 independent Emulations in one consumable, Chip-Array optimizes workflows and reduces cell requirements—delivering scalable, physiologically relevant models for advanced research.

36. Curia R&D Pipeline Overview 2/18/2026

    This pipeline outlines a sequence of late‑stage and emerging therapeutics projected to launch between 2024 and 2031, spanning immunology, neurology, psychiatry, rare disease, oncology, and inflammatory disorders.

37. Compact And Tunable Absorbance Microplate Readers 4/4/2025

    Explore a microplate reader that offers cost-effective versatility, combines filter-based affordability with monochromator adaptability, and supports cuvette and microplate applications that are ideal for diverse laboratory needs.

38. Duodenum Intestine Bio-Kit 2/13/2024

    The human small intestine plays a critical role in human health and gastrointestinal disease but remains challenging to study. Learn about a duodenum intestine model that offers a viable solution.

39. Accelerating FIH Trials To POC With Speed, Safety, And Certainty 10/15/2025

    Overcome clinical transition challenges with integrated services, including study design, expert regulatory support, robust recruitment, and flexible manufacturing.

40. Integrated Programs To Bridge Molecules From Discovery Into Clinical Development 1/4/2023

    A new collaboration helps to remove obstacles from the critical path, reduce development risks, eliminate the white space in pre-clinical drug development, and shorten the pathway to clinical development.